Vermillion Wealth Management, Inc. Sorrento Therapeutics, Inc. Transaction History
Vermillion Wealth Management, Inc.
- $341 Billion
- Q1 2025
A detailed history of Vermillion Wealth Management, Inc. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 70 shares of SRNE stock, worth $23. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70Holding current value
$23% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRNE
# of Institutions
14Shares Held
5.5MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Goodman Advisory Group, LLC102KShares$33,4960.28% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...